Abstract
摘要
相似文献
1
[Experience with sodium carbenoxolone].
Med Klin. 1971 May;66(22):822-5.
2
[Plasma renin activity, aldosterone excretion rate, serum electrolytes and blood pressure before and following treatment with carbenoxolone-sodium].
Verh Dtsch Ges Inn Med. 1971;77:1008-13.
3
Controlled double blind trial of carbenoxolone in gastric and duodenal ulcer.
Int J Clin Pharmacol. 1974 Dec;10(4):309-18.
4
[Carbenoxolone in the treatment of stomach and duodenal ulcers].
Z Allgemeinmed. 1973 Nov 30;49(33):1646-8.
5
[Carbenoxolone in therapy resistant stomach and duodenal ulcer].
Med Welt. 1971 Sep 25;39:1527-8.
6
[Carbenoxolone-natrium in treatment of stomach and duodenal ulcer].
Med Welt. 1971 Sep;22(36):1394-7.
7
[Treatment of gastric and duodenal ulcers using carbenoxolone sodium. (Double blind trial)].
Munch Med Wochenschr. 1972 May 12;114(19):925-9.
8
[Carbenoxolon in treatment of stomach ulcer, duodenal ulcer and ulcerative colitis].
Z Allgemeinmed. 1972 Oct 31;48(30):1411-4.
9
Carbenoxolone in the treatment of gastric ulcer.
Am J Gastroenterol. 1973 Jul;60(1):23-9.
10
Proceedings: A double blind trial of carbenoxolone and geranyl farnesylacetate in gastric ulcer.
Gut. 1974 Oct;15(10):833.
引用本文的文献
1
Medical management of peptic ulcer with reference to anti-ulcer agents in other gastro-intestinal diseases.
Drugs. 1972;3(5):366-403. doi: 10.2165/00003495-197203050-00005.
2
Carbenoxolone sodium.
Gut. 1972 Oct;13(10):816-24. doi: 10.1136/gut.13.10.816.
3
Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.
Drugs. 1976;11(4):245-307. doi: 10.2165/00003495-197611040-00002.
Zotero 插件